CALIDI BIOTHERAPEUTICS INC (CLDI)

US3207033099 - Common Stock

1.36  -0.09 (-6.21%)

Premarket: 1.27 -0.09 (-6.62%)

CALIDI BIOTHERAPEUTICS INC

NYSEARCA:CLDI (12/20/2024, 8:04:02 PM)

Premarket: 1.27 -0.09 (-6.62%)

1.36

-0.09 (-6.21%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS SubIndustryBiotechnology
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%-486.95%
Sales Q2Q%N/A
CRS9.39
6 Month-24.86%
Overview
Earnings (Last)11-12 2024-11-12/amc
Earnings (Next)N/A N/A
Ins Owners11.66%
Inst Owners3.46%
Market Cap23.83M
Shares17.52M
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts87.5
Short Float %5.97%
Short Ratio0.48
IPO09-10 2021-09-10
Stock Screener Links
Screen Image

American Stock Exchange Stock Screener

Find more stocks on American Stock Exchange

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

CLDI Daily chart

Company Profile

Calidi Biotherapeutics Inc is a US-based company operating in Biotechnology industry. The company is headquartered in San Diego, California and currently employs 41 full-time employees. The company went IPO on 2021-09-10. Calidi Biotherapeutics, Inc. is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The firm's novel stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in multiple oncology indications, including high-grade gliomas and solid tumors. Its clinical-stage off-the-shelf, universal cell-based delivery platforms are designed to protect, amplify, and potentiate oncolytic viruses. Its preclinical off-the-shelf enveloped virotherapies are designed to target disseminated solid tumors. This dual approach shall potentially treat, or even prevent, metastatic disease. Its product candidates include CLD-101 for Recurrent HGG; CLD-201 for Advanced Solid Tumors, and CLD-400 (RTNova) for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline product candidates, the Company's is also engaged in discovery research of CLD-301 (AAA) for multiple Indications.

Company Info

CALIDI BIOTHERAPEUTICS INC

4475 Executive Drive, Suite 200

San Diego CALIFORNIA

P: 18587949600

Employees: 41

Website: https://www.calidibio.com/

CLDI News

News Imagea month ago - Calidi Biotherapeutics, IncCalidi Biotherapeutics Announces Closing of $7.5 Million Public Offering of Common Stock

SAN DIEGO, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company...

News Imagea month ago - Calidi Biotherapeutics, IncCalidi Biotherapeutics Announces Pricing of $7.5 Million Public Offering of Common Stock

SAN DIEGO, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a clinical-stage...

News Imagea month ago - Calidi Biotherapeutics, IncCalidi Biotherapeutics Announces Proposed Public Offering

SAN DIEGO, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a clinical-stage...

News Imagea month ago - Calidi Biotherapeutics, IncCalidi Biotherapeutics Reports Third Quarter 2024 Operating and Financial Results

Announced FDA Clearance of the Northwestern University IND Application for NeuroNova (CLD-101) Clinical Trial in High-Grade Glioma.Presented data...

News Image2 months ago - ACCESSWIRENexalin Technology and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
News Image2 months ago - Calidi Biotherapeutics, IncCalidi Biotherapeutics to Present Data Supporting RTNova at Upcoming Scientific Conferences

- RTNova, an innovative systemic antitumor enveloped virotherapy, unlocks new possibilities in cancer therapy - RTNova addresses challenges posed by...

CLDI Twits

Here you can normally see the latest stock twits on CLDI, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example